John Bournas
Chief Executive Officer at World Federation of Hemophilia
Profile
John Bournas is currently the Chief Executive Officer & Executive Director at the World Federation of Hemophilia.
Previously, he served as the President & Chief Executive Officer at the International Society for Pharmaceutical Engineering.
Mr. Bournas completed his undergraduate degree at Fairleigh Dickinson University, his graduate degree at Fordham University, and his MBA at Macquarie University.
John Bournas active positions
Companies | Position | Start |
---|---|---|
World Federation of Hemophilia | Chief Executive Officer | - |
Former positions of John Bournas
Companies | Position | End |
---|---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Chief Executive Officer | - |
Training of John Bournas
Macquarie University | Masters Business Admin |
Fordham University | Graduate Degree |
Fairleigh Dickinson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
World Federation of Hemophilia |
- Stock Market
- Insiders
- John Bournas